today show glp-1 drugs, like Ozempic and Wegovy, offer an “extraordinary opportunity to change…the health of our country,” Dr. David Kessler says, but he cautions that “there is no endgame” for getting off of Your guide to GLP-1 weight

The most accurate way to discuss them is to identify where the evidence comes from and what it cannot establish

Sanetra AM, Palus-Chramiec K, Chrobok L, Jeczmien-Lazur JS, Klich JD, Lewandowski MH

Understanding GHK-CU mechanisms requires examining how this tripeptide interacts with copper and cellular receptors

Future research should focus on long-term outcomes, optimal treatment protocols, patient selection criteria, and strategies to ensure equitable access

Genetic testing for UGT1A1, GSTM1, GSTT1, NAT2, COMT, and SULT1A1 variants helps identify fixed (non-modifiable) conjugation bottlenecks that require lifelong compensatory strategies